SMO ClinPlus CO.,LTD. Statistics
Total Valuation
SHE:301257 has a market cap or net worth of CNY 2.23 billion. The enterprise value is 1.37 billion.
Market Cap | 2.23B |
Enterprise Value | 1.37B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SHE:301257 has 79.50 million shares outstanding. The number of shares has increased by 14.69% in one year.
Current Share Class | 79.50M |
Shares Outstanding | 79.50M |
Shares Change (YoY) | +14.69% |
Shares Change (QoQ) | -29.09% |
Owned by Insiders (%) | 13.41% |
Owned by Institutions (%) | 21.93% |
Float | 42.20M |
Valuation Ratios
The trailing PE ratio is 25.96 and the forward PE ratio is 20.28.
PE Ratio | 25.96 |
Forward PE | 20.28 |
PS Ratio | 2.80 |
PB Ratio | 1.88 |
P/TBV Ratio | 1.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.73, with an EV/FCF ratio of -39.21.
EV / Earnings | 15.06 |
EV / Sales | 1.72 |
EV / EBITDA | 12.73 |
EV / EBIT | 14.52 |
EV / FCF | -39.21 |
Financial Position
The company has a current ratio of 5.86, with a Debt / Equity ratio of 0.00.
Current Ratio | 5.86 |
Quick Ratio | 5.85 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | -0.02 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.97% and return on invested capital (ROIC) is 5.14%.
Return on Equity (ROE) | 7.97% |
Return on Assets (ROA) | 4.24% |
Return on Invested Capital (ROIC) | 5.14% |
Return on Capital Employed (ROCE) | 8.00% |
Revenue Per Employee | 169,579 |
Profits Per Employee | 19,421 |
Employee Count | 4,186 |
Asset Turnover | 0.57 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.56% in the last 52 weeks. The beta is 0.90, so SHE:301257's price volatility has been similar to the market average.
Beta (5Y) | 0.90 |
52-Week Price Change | -17.56% |
50-Day Moving Average | 29.69 |
200-Day Moving Average | 28.60 |
Relative Strength Index (RSI) | 45.63 |
Average Volume (20 Days) | 1,915,792 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301257 had revenue of CNY 795.66 million and earned 91.12 million in profits. Earnings per share was 1.08.
Revenue | 795.66M |
Gross Profit | 177.89M |
Operating Income | 94.51M |
Pretax Income | 102.87M |
Net Income | 91.12M |
EBITDA | 100.85M |
EBIT | 94.51M |
Earnings Per Share (EPS) | 1.08 |
Balance Sheet
The company has 854.01 million in cash and 607,941 in debt, giving a net cash position of 853.40 million or 10.73 per share.
Cash & Cash Equivalents | 854.01M |
Total Debt | 607,941 |
Net Cash | 853.40M |
Net Cash Per Share | 10.73 |
Equity (Book Value) | 1.18B |
Book Value Per Share | 14.30 |
Working Capital | 1.14B |
Cash Flow
In the last 12 months, operating cash flow was -28.58 million and capital expenditures -6.41 million, giving a free cash flow of -34.99 million.
Operating Cash Flow | -28.58M |
Capital Expenditures | -6.41M |
Free Cash Flow | -34.99M |
FCF Per Share | -0.44 |
Margins
Gross margin is 22.36%, with operating and profit margins of 11.88% and 11.45%.
Gross Margin | 22.36% |
Operating Margin | 11.88% |
Pretax Margin | 12.93% |
Profit Margin | 11.45% |
EBITDA Margin | 12.68% |
EBIT Margin | 11.88% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 0.64%.
Dividend Per Share | 0.18 |
Dividend Yield | 0.64% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 24.23% |
Buyback Yield | -14.69% |
Shareholder Yield | -14.05% |
Earnings Yield | 4.09% |
FCF Yield | -1.57% |
Stock Splits
The last stock split was on June 6, 2024. It was a forward split with a ratio of 1.3000013.
Last Split Date | Jun 6, 2024 |
Split Type | Forward |
Split Ratio | 1.3000013 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |